Management of Joint Replacement in Hemophilia a with Inhibitors during Emicizumab Prophylaxis

被引：0
|
作者：
Santagostino, Elena
Mancuso, Maria Elisa
Novembrino, Cristina
Boscolo, Massimo Anzoletti
Clerici, Marigrazia
Pasta, Gianluigi
Solimeno, Luigi Piero
Peyvandi, Flora
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2360
引用
收藏
页数：3
相关论文
共 50 条
  • [41] RESOURCE CONSUMPTION ANALYSIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS ON PROPHYLAXIS WITH FVIII BEFORE SWITCHING TO EMICIZUMAB
    Giacomini, E.
    Leogrande, M.
    Motta, L.
    Tempre, R.
    Bendinelli, S.
    Degli Esposti, L.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S69 - S69
  • [42] Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors
    Escobar, Miguel
    Agrawal, Neha
    Chatterjee, Sagnik
    Bhattacharya, Swastik
    Caicedo, Jorge
    Bullano, Michael
    Schultz, Bob G. G.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 574 - 580
  • [43] Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
    Garcia, Jessica
    Hammer, Matthew R.
    Zia, Ayesha
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
  • [44] An Investigational Dosing Algorithm of Emicizumab for Prophylaxis in Acquired Hemophilia a
    Shima, Midori
    Nagami, Sayaka
    Yoneyama, Koichiro
    Nomura, Akira
    Ogawa, Yoshiyuki
    Amano, Kagehiro
    Nogami, Keiji
    [J]. BLOOD, 2020, 136
  • [45] Management and Outcomes of Invasive Procedures in Individuals with Hemophilia A on Emicizumab Prophylaxis: A Single Center Experience
    Rener, Karla
    Anzej Doma, Sasa
    Fink, Martina
    Podgornik, Helena
    Preloznik Zupan, Irena
    Cerchione, Claudio
    Zanon, Ezio
    [J]. HEMATOLOGY REPORTS, 2023, 15 (04) : 597 - 607
  • [46] Hemophilia A in infantsEffective prophylaxis with emicizumab possible at an early stage
    Burggraf, Leoni
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (05)
  • [47] Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis
    Hermans, Cedric
    Ventriglia, Giuliana
    Obaji, Samya
    Beckermann, Benjamin M.
    Lehle, Michaela
    Catalani, Olivier
    d'Oiron, Roseline
    Frenzel, Laurent
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
  • [48] Hemlibra® (Emicizumab) receives EU Approval for Routine Prophylaxis of Hemophilia A with Inhibitors against Coagulation Factor VIII
    不详
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2018, 45 (02)
  • [49] Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis
    Shimonishi, Naruto
    Sasai, Kana
    Ogiwara, Kenichi
    Furukawa, Shoko
    Nakajima, Yuto
    Mizumachi, Kuniyoshi
    Yada, Koji
    Takeyama, Masahiro
    Shima, Midori
    Mizuno, Narumi
    Nogami, Keiji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (06) : 690 - 698
  • [50] BUDGET IMPACT ANALYSIS OF THE USE OF EMICIZUMAB IN PROPHYLAXIS FOR SEVERE HEMOPHILIA A AND INHIBITORS IN THE PEDIATRIC COPULATION OF THE DOMINICAN REPUBLIC
    Munoz, A.
    Bustamante, A.
    Blanco, J.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S135 - S136
12345